Biotricity, Inc. (BTCY) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Redwood City, CA, 미국. 현재 CEO는 Waqaas Al-Siddiq.
BTCY 을(를) 보유 IPO 날짜 2018-02-16, 55 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $7.68M.
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
